Publications by authors named "Natasha Schouten"
Background And Objective: Clinical practice guidelines for prostate cancer (PCa) are a valuable resource for everyday clinical practice. The clinical practice guidelines and recommendations produced by various societies should demonstrate a considerable level of consistency in terms of quality, regardless of the society that developed these given the common evidence base. However, to date, no study has assessed the quality of PCa clinical practice guidelines.
View Article and Find Full Text PDFArticle Synopsis
- The 2024 guidelines for treating relapsing, metastatic, and castration-resistant prostate cancer (PCa) have been updated by several European medical associations based on new research from 2020 to 2023.
- The updated guidelines include risk stratification to help determine salvage therapy options and highlight new treatment options like ARTAs, PARP inhibitors, and prostate-specific membrane antigen-based therapy.
- These guidelines emphasize the need for a multidisciplinary approach to PCa management and are updated annually to reflect the latest evidence, with the full details available online.
Background And Objective: The European Association of Urology (EAU) Guidelines Panel on non-neurogenic male lower urinary tract symptoms (LUTS) aimed to develop a new subchapter on underactive bladder (UAB) in non-neurogenic men to inform health care providers of current best evidence and practice. Here, we present a summary of the UAB subchapter that is incorporated into the 2024 version of the EAU guidelines on non-neurogenic male LUTS.
Methods: A systematic literature search was conducted from 2002 to 2022, and articles with the highest certainty evidence were selected.
Background And Objective: The European Association of Urology (EAU)-European Association of Nuclear Medicine (EANM)-European Society for Radiotherapy and Oncology (ESTRO)-European Society of Urogenital Radiology (ESUR)-International Society of Urological Pathology (ISUP)-International Society of Geriatric Oncology (SIOG) guidelines provide recommendations for the management of clinically localised prostate cancer (PCa). This paper aims to present a summary of the 2024 version of the EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on the screening, diagnosis, and treatment of clinically localised PCa.
Methods: The panel performed a literature review of all new data published in English, covering the time frame between May 2020 and 2023.
Article Synopsis
- The 2024 EAU guidelines for neurourology emphasize the importance of lifelong management for patients with neurological conditions affecting urinary, sexual, and bowel functions.
- The guidelines were updated based on a literature review from 2021-2023, with evidence and strength ratings assigned to each recommendation to ensure a comprehensive approach to diagnosis and treatment.
- Key recommendations include early diagnosis, customized management plans involving multidisciplinary care, and continuous follow-up to maintain patients' quality of life.
Context: The European Association of Urology (EAU) Guidelines Panel for Urological Trauma has produced guidelines in order to assist medical professionals in the management of urological trauma in adults for the past 20 yr. It must be emphasised that clinical guidelines present the best evidence available to the experts, but following guideline recommendations will not necessarily result in the best outcome. Guidelines can never replace clinical expertise when making treatment decisions for individual patients regarding other parameters such as experience and available facilities.
View Article and Find Full Text PDFFrom BPH to male LUTS: a 20-year journey of the EAU guidelines.
Prostate Cancer Prostatic Dis
March 2024
Context: Lower urinary tract symptoms (LUTS) are common, often bothersome, and have multifactorial aetiology.
Objective: To present a summary of the 2023 version of the European Association of Urology guidelines on the management of male LUTS.
Evidence Acquisition: A structured literature search from 1966 to 2021 selected the articles with the highest certainty evidence.
Background: Evidence-practice gaps exist in urology. We previously surveyed European Association of Urology (EAU) guidelines for strong recommendations underpinned by high-certainty evidence that impact patient experience for which practice variations were suspected. The recommendation "Do not offer neoadjuvant androgen deprivation therapy (ADT) before surgery for patients with prostate cancer" was prioritised for further investigation.
View Article and Find Full Text PDFContext: Urinary incontinence (UI) is a common condition in elderly men causing a severe worsening of quality of life, and a significant cost for both patients and health systems.
Objective: To report a practical, evidence-based, guideline on definitions, pathophysiology, diagnostic workup, and treatment options for men with different forms of UI.
Evidence Acquisition: A comprehensive literature search, limited to studies representing high levels of evidence and published in the English language, was performed.